Harmony Biosciences Holdings, Inc. (HRMY) short interest & options flow
NASDAQHarmony Biosciences heads into its November 4 Q3 earnings print with shorts at their most aggressive in months and options traders paying heavily for downside protection. The short interest story is genuinely meaningful here. Bears have added to positions steadily since early October, with SI rising nearly 20% over the past month to reach almost 10% of the free float. That is a…
HRMY retail attention hits 7.2 standard deviations above its own 90-day average, per Wikipedia views and ORTEX stock page data, signaling surge in retail investor focus ahead of October 27 earnings.
- Market cap
- $2.26B
- Next earnings
- 4 Nov 2026
Key data as of 3 Nov 2026
Latest signals on HRMY
- Alt Data
HRMY retail attention hits 7.2 standard deviations above its own 90-day average, per Wikipedia views and ORTEX stock page data, signaling surge in retail investor focus ahead of October 27 earnings.
HRMY news and analysis
RSSNo long-form analysis yet for HRMY. Pulse alerts and the live data picture are available on ORTEX.
Open HRMY on ORTEX →Want the live picture for HRMY?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HRMY — free to start on ORTEX.
Sign up for free →Open HRMY on ORTEX